GLAM
OCAT

Gardner Lewis Asset Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Gardner Lewis Asset Management’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-749,357
Closed -$6.31M – 96
2015
Q4 		$6.31M Buy
+749,357
New +$5.01M 0.99% 33

Gardner Lewis Asset Management's OCAT Position: Q1 2016 in Review

Gardner Lewis Asset Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 749,357 shares — an estimated $6.31M sold.

Gardner Lewis Asset Management first reported a position in OCAT in Q4 2015 and held it in 1 quarter. The position peaked at $6.31M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Gardner Lewis Asset Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 749,357 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $6.31M.
  • Gardner Lewis Asset Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q4 2015 and held it in 1 quarter.
  • Gardner Lewis Asset Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $6.31M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2016, filed 12 May 2016.